Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05727969
Other study ID # M637
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 15, 2023
Est. completion date December 15, 2023

Study information

Verified date February 2024
Source Fayoum University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This non-invasive dimensionless score index -SPI-reflects the Patients' sympathetic response to surgical stimulation. Its effectiveness in detecting the balance between nociceptor activation and analgesia was not only reported but also, was reported to be superior to the other parameters like blood pressure and heart rate. SPI value is correlated to pain and ranges from 0 to 100, higher values indicate strong surgical stimulus. Its value is obtained from photoplethysmographic amplitude (PPGA) and heart rate (HR) data from pulse oximetry measurement. Prediction of the severity of postoperative pain using SPI in both adults and children has been reported by several studies. So, the authors hypothesize that dexmedetomidine infusion without giving a bolus dose may affect the SPI in pediatrics undergoing hypospadias repair.


Description:

After obtaining Fayoum University's ethical committee permission and as well as the informed consent from the parents, 90 patients aged 1 to 7 years old scheduled for hypospadias repair will be randomly assigned into 2 groups. Preoperative Assessment: All patients will be assessed clinically and investigated for exclusion of any of the above-mentioned contraindications. Perioperative Management: Patients will receive no premedication. After entering the Operating room, All patients will be monitored using surgical pleth index, arterial blood pressure, pulse oximetry, and electrocardiography. The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system. Inhalational induction of general anesthesia (GA) will be performed with a face mask using sevoflurane 8% and 50% oxygen in the air, and then an intravenous (IV) cannula will be inserted. Fentanyl will be administered intravenously at 1 μg/kg, atracurium 0.5 mg/kg and an endotracheal tube will be used to secure the airway. Anesthesia will be maintained with 1% isoflurane, 50% oxygen in the air, and atracurium infusion (0.10 mg/kg). During the operation, bradycardia is defined as a 30% decrease from the baseline HR, and hypotension is defined as a 30% decrease from the baseline MAP. In these cases, 0.01 mg/kg of atropine and 0.1 mg/kg of ephedrine, respectively, will be given intravenously. Additionally, tachycardia is defined as a 30% increase from the baseline HR, and hypertension is defined as a 30% increase from the baseline MAP. If either of these occurred, 0.1 μg/kg of fentanyl was given intravenously, and then the incidence was calculated and analyzed. At the end of the surgery, acetaminophen 15 mg/kg IV will be administered to all patients. After completion of the surgical procedure and emergence from anesthesia, the patient will be referred to PACU. Quality of analgesia will be assessed using a face, legs, activity, cry, consolability (FLACC scale) at PACU discharge and 2, 4, 6, 12, and 24 hours postoperatively. Diclofenac sodium 1 mg/kg rectally will be given as rescue analgesia for patients in all study groups in PACU if the FLACC scale > 4. Nurses will be informed about the pain evaluation, to give the patients oral paracetamol 30 mg/kg. The data collectors from nurses will record data. The depth of sedation will be assessed using Ramsy sedation score (RSS) at PACU discharge and 2 hours postoperative by the investigators. The patient will be discharged from PACU using The Modified Aldrete Score system after an assessment of the patient's activity, respiration, blood pressure, consciousness, and color, A score ≥ 9 is required for discharge from the PACU. Adverse events like bradycardia hypotension excessive sedation respiratory depression postoperative agitation nausea and vomiting will be recorded during the first 24 hours. Statistical analysis - Sample size calculation was done using IBM SPSS version 29 for Windows. A total of 45 children per group are needed to be able to detect an expected difference in the SPI based on previous research.This sample size was estimated using a power of 80% and alpha of 0.05. - Descriptive statistics for the variables will be presented in the form of mean with standard deviation or median with interquartile range for numeric variables, while frequencies and percentages will be used for categorical variables. Comparison of the two groups will be done after testing for normality of the distribution using Shapiro-wilk test. The analysis will be done using the independent samples t test or using the non-parametric Mann Whitney test for numerical variables. Categorical variables will be compared using Chi Square test or Fisher's exact test. IBM SPSS version 28 for Windows software will be used for the analysis. A p-value of < 0.05 will be considered statistically significant.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date December 15, 2023
Est. primary completion date November 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 1 Year to 7 Years
Eligibility Inclusion Criteria: - Age 1-7years. - ASA physical status I-II. - Hypospadias surgery. Exclusion Criteria: - Children having a history of mental retardation. - Developmental delay. - Allergic to dexmedetomedine. - Neuraxial anesthesia. - Cardiovascular disease.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Dexmedetomidine
Dexmedetomidine at a a rate of 0.5 µg/kg/hour will be infused with induction of anesthesia.
Lactated Ringer
Lactated ringer solution at a a rate of 0.5 µg/kg/hour will be infused with induction of anesthesia.
Procedure:
Hypospadias
Children who will undergone hypospadias surgery
Device:
Surgical pleth index
The SPI value will be measured using Datex-Ohmeda (GE Healthcare,Madison,WI 53707-7550 USA) monitoring system.

Locations

Country Name City State
Egypt Fayoum University hospital Madinat al Fayyum Faiyum Governorate

Sponsors (1)

Lead Sponsor Collaborator
Fayoum University Hospital

Country where clinical trial is conducted

Egypt, 

References & Publications (3)

Constant I, Sabourdin N. Monitoring depth of anesthesia: from consciousness to nociception. A window on subcortical brain activity. Paediatr Anaesth. 2015 Jan;25(1):73-82. doi: 10.1111/pan.12586. Epub 2014 Nov 20. — View Citation

Hamunen K, Kontinen V, Hakala E, Talke P, Paloheimo M, Kalso E. Effect of pain on autonomic nervous system indices derived from photoplethysmography in healthy volunteers. Br J Anaesth. 2012 May;108(5):838-44. doi: 10.1093/bja/aes001. Epub 2012 Feb 26. — View Citation

Huiku M, Uutela K, van Gils M, Korhonen I, Kymalainen M, Merilainen P, Paloheimo M, Rantanen M, Takala P, Viertio-Oja H, Yli-Hankala A. Assessment of surgical stress during general anaesthesia. Br J Anaesth. 2007 Apr;98(4):447-55. doi: 10.1093/bja/aem004. Epub 2007 Feb 28. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Age in years 1 hour preoperatively
Other American society of anesthesiology classification Either I: normal healthy or II: mild systemic disease 1 hour preoperatively
Primary Surgical pleth index number from 0 to 100, higher values indicate strong surgical stimulus 1 minute at end of the operation after skin closure.
Secondary Surgical pleth index number from 0 to 100, higher values indicate strong surgical stimulus 1 minute before induction of anesthesia.
Secondary Surgical pleth index number from 0 to 100, higher values indicate strong surgical stimulus 1 minute after insertion of endotracheal tube.
Secondary Surgical pleth index number from 0 to 100, higher values indicate strong surgical stimulus 1 minute after beginning of surgery with skin incision.
Secondary Surgical pleth index number from 0 to 100, higher values indicate strong surgical stimulus 5 minutes after recovery at post anesthesia care unit.
Secondary Mean arterial blood pressure in mmHg 5 minutes after recovery at post anesthesia care unit.
Secondary Mean arterial blood pressure in mmHg 1 minute before induction of anesthesia.
Secondary Mean arterial blood pressure in mmHg 1 minute after beginning of surgery with skin incision.
Secondary Heart rate beat/minute 1 minute after beginning of surgery with skin incision.
Secondary Heart rate beat/minute 1 minute before induction of anesthesia.
Secondary Heart rate beat/minute 5 minutes after recovery at post anesthesia care unit.
Secondary Heart rate beat/minute 1 minute at end of the operation after skin closure.
Secondary Mean arterial blood pressure mmHg 1 minute at end of the operation after skin closure.
Secondary Need of vasoactive drugs Yes or no 1minute after infusion until end of surgery
Secondary FLACC pain score F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children 5 minutes after recovery in postanesthesia care unit
Secondary FLACC pain score F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children 2 hours after recovery in postanesthesia care unit
Secondary Ramsay sedation score 0:5 with 0:deeply sedation to 5:no sedation 5 minutes after recovery in postanesthesia care unit
Secondary Ramsay sedation score 0:5 with 0:deeply sedation to 5:no sedation 2 hours after recovery in postanesthesia care unit
Secondary FLACC pain score F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children 4 hours after discharge from recovery
Secondary FLACC pain score F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children 6 hours after discharge from recovery
Secondary FLACC pain score F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children 12 hours after discharge from recovery
Secondary FLACC pain score F:face - L:legs - A:activity - C:cry - C:consolability for description of pain degree in children 24 hours after discharge from recovery
Secondary Surgical time from when the surgeon of record starts the procedure until complete skin closure in minutes 1 minute after skin
Secondary Anesthesia time from the start of anesthesia to the end of an anesthesia service in minutes 5 minutes after insertion of endotracheal tube
Secondary Total opioid consumption in milligram 24 hours after operation
Secondary Time of 1st analgesia dose time when first analgesic drug is injected for pain (in hours) 24 hours postoperatively
Secondary Total non-steroidal consumption time when first usage of non-steroidal anti-inflammatory drug is injected for pain (in hours) 24 hours postoperatively
Secondary Extubation time time from the end of surgery to airway extubation (in minutes) 2 minutes after removal of endotracheal tube
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care